FMR CORP 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-12 09:25 am Sale |
2021-10-08 | 13G | Theravance Biopharma, Inc. TBPH |
FMR CORP | 2,670,881 3.635% |
-6,936,429 (-72.20%) |
Filing |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Theravance Biopharma, Inc. TBPH |
FMR CORP | 9,607,310 15.000% |
1,083,137 (+12.71%) |
Filing |